AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2017
May 16, 2017
33483_dirs_2017-05-16_14d66e9b-92b1-433e-a54e-9a4c4fefec80.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-05-16
Reporting Person: KANIA EDWIN M JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-16 | Common Stock | S | 266795 | $14.00 | Disposed | 560067 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 26528 | Direct |
Footnotes
F1: Held by Flagship Ventures Fund 2007, L.P. ("Flagship 2007"). Flagship Ventures 2007 General Partner LLC ("Flagship 2007 LLC") is the general partner of Flagship 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship 2007 LLC. Flagship 2007 LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship 2007. Mr. Kania disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F2: Includes 26,528 shares that was previously received by Mr. Kania in a pro rata distribution by Flagship 2007 LLC that was exempt from reporting pursuant to Rule 16a-13.